C and washed once with cold water before pellets were resuspended in an equal volume of lysis buffer (100 mM HEPES-KOH pH 8.0, 10% glycerol, 10 mM EGTA, 0.1 mM EDTA, 0.4% NP-40, 600 mM NaOAc, 1 mM PMSF, 1 mM DTT and 1× protease inhibitor cocktail (Roche)). Cells were lysed by vortexing 12 × 20 s with zirconia/silica beads using a BEAD-BEATER machine (Biospec Products) at 4 0 C. Cell lysates were cleared with a 10 min, 3000 rpm spin at 4 0 C, protein concentrations were checked by Bradford and two samples were diluted to same concentration with lysis buffer plus inhibitors. For immunoprecipitation 150 µl of Rabbit IgG (Sigma I5006)-coupled magnetic Epoxy beads (Dynabeads M-270; Dynal Biotech ASA, Invitrogen) were added and tubes were rotated for 3 hr at 4 0 C. Beads were collected with a magnet, washed three times with 1 ml lysis buffer, and eluted with 90 µl of 1× SDS-PAGE sample buffer (10 min at +65°C) for electrophoresis. Samples were run on 7.5%, 10% and 15% SDS-PAGE gels (30 µl of sample loaded on each) and visualized by silver staining (Blum et al., 1987) . For the phosphopeptide analysis the purification was done in similar fashion with few exceptions: cell were grown in 6 liters of YPAD, phosphatase inhibitors were added to the lysis buffer (PPi: 10 mM NaF, 10 mM NaN 3 , 10 mM pnitrophenylphosphate, 10 mM Na 2 P 2 O 4 , and 10 mM β-glycerophosphate), 300 µl of IgG coupled magnetic beads were used for the immunoprecipitation and proteins were detected by Colloidal Coomassie Staining (Neuhoff et al., 1985) .
Mass spectrometric identification of protein bands and phosphopeptide analysis
For protein identification, bands were excised from silver-stained gels, cut into smaller pieces, washed 3 times with water, dehydrated with acetonitrile (ACN) and dried in a Speedvac. Disulfide bonds were reduced with 10 mM DTT for 30 min at 56 0 C, and after a dehydrating step with ACN, alkylated with 10 mg/ml iodacetamide for 20 min in the dark. Gel pieces were washed twice with 50mM ammonium bicarbonate (ABC), dehydrated with ACN and dried in a Speedvac. Proteins were digested with trypsin (Roche) at a concentration of 10 ng/µl in 50 mM ABC at 37 0 C for 16 hours. The reaction was stopped by the addition of formic acid to a final concentration of 1%. Peptides were extracted from the gel with 5% formic acid and separated by nano reversed-phase HPLC (Ultimate, Switchos, Famos, LC Packings). Samples were concentrated and desalted on a trapping column (PepMap C18, 300µm x 5mm) with 0.1% trifluoroacetic acid at a flow rate of 20 µl/min. Bound peptides were eluted and separated on a 75 µm x 150 mm analytical column, packed with the same material, using a linear gradient from 2.5% to 40% ACN in 60 min and a flow rate of 250 nl/min. The LC was directly coupled to an LTQ (ThermoScientific) linear ion trap mass spectrometer via a nanoelectrospray ion source (Proxeon). The instrument was operated in data dependent mode: one fullscan was followed by MS/MS scans of the four most abundant ions, former precursors were excluded from MS/MS for 30 seconds. All tandem mass spectra were searched against a yeast protein database (downloaded from SGD on 01-20-2006, common contaminant proteins added) using MASCOT 2.1 (Matrix Science). Precursor mass accuracy was set to 2 Da, fragment ion mass accuracy was set to 0.8 Da, and a maximum of two missed cleavages was allowed. Carbamidomethylation of Cys was set as a fixed modification and oxidation of Met was set as a variable modification. Score values were derived from the MASCOT database search engine and are a measure for the significance of the protein identification (the higher the score the more confident the match). All protein hits were validated manually. Predicted molecular masses and descriptions of protein function indicated in Figure 1B are derived from Saccharomyces Genome Database (www.yeastgenome.org).
For phosphorylation analysis, bands were cut from Coomassie-stained gels, destained with 40% ACN/60% 50mM ABC and reduced and alkylated as described above. For optimal sequence coverage three different digests were performed. Chymotrypsin (Roche) was used at a concentration of 10 ng/µl in 50mM ABC for 16 hours at 25 0 C, subtilisin (Fluka) was used at a concentration of 100 ng/µl in 5.4M urea/0.1M Tris pH 8 for 1hour at 37°C. In addition, a trypsin/chymotrypsin double digestion was performed by adding 200 ng chymotrypsin to a 16 h tryptic digest (see above) and incubating the mixture for an additional 5 hours at 25 0 C. All digests were stopped with formic acid (1% final concentration). Nano-HPLC was performed as described above but with a gradient from 2.5% to 40% ACN in 3 hours. Samples were analyzed either on an LTQ (chymotryptic and tryptic/chymotryptic digests) or on an LTQ-FT (subtilisin digest) instrument (both from Thermo Scientific), using neutral loss triggered MS3 analysis (Beausoleil et al., 2004; Olsen and Mann, 2004) . In this mode the (often predominant) fragment corresponding to the neutral loss of phosphoric acid from phosphoserine or phosphothreonine residues in an MS2 spectrum is selected as precursor for an additional stage of mass spectrometric analysis (MS3) to improve the information content of the spectra. Spectra were searched against the database described above using the SEQUEST algorithm in the BioworksBrowser 3.2 software package (Thermo Scientific). Carbamidomethylation of Cys was set as a fixed modification; oxidation of Met, phosphorylation of Ser, Thr and Tyr, as well as loss of water from Ser and Thr, were set as variable modifications. Four (chymotryptic digest) or five (tryptic/chymotryptic double digest) missed cleavages were allowed. The subtilisin digest was searched with no enzyme specificity. Precursor mass accuracy was set to 2.5 amu for LTQ data or to 20 ppm for LTQ-FT data. Fragment mass accuracy was set to 1 amu. All phosphosites assigned by the software were validated manually.
Chemical Fragmentation Analysis
NTCB chemical fragmentation analysis was done as described before (Urban et al., 2007) . Strains used in the experiments were made prototroph by introducing the lacking amino acid and nucleotide genes with the appropriate centromeric pRS series plasmids (Sikorski and Hieter, 1989) or pJU450 (Urban et al., 2007) . Quantification of band intensities was done with Quantitity One® software (BioRad); band intensities were normalized to background and ratio between phosphorylated and unphosphorylated form of Sch9 was calculated by dividing the higher band (+Pi) value with lower band (-Pi) value. In each individual experiment the ratios were normalized to the value of the untreated wildtype sample to provide the relative +P i /-P i values indicated in the figures.
For the Sfp1 overexpression experiment ( Figure 6B ) SFP1 expression was induced by adding galactose (2%) for indicated times to cells growing on SC-Leu-Trp + 2% raffinose. These cells contained an integrated GAL1 promoter-driven SFP1 gene (GAL1-SFP1; HL202) and in addition a centromeric plasmid containing SFP1 (pHL101, to supply normal levels of Sfp1 before galactose-induced overexpression) and an Sch9-5HA-expressing plasmid (pJU679). A wildtype strain (YDS2), which also contained the pHL101 and pJU679, was used as control. Figure S1 . Purification of Sfp1 interacting proteins Purified proteins from an immunoprecipitation of Sfp1-TAP, as described in Figure 1A , were separated and silver stained using 10% (A) and 15% (B) SDS-PAGE gels. Unique protein bands identified by mass spectrometry are indicated.
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Figure S2. Regulation of Sfp1 phosphorylation, localization and interaction with TORC1. (A)
Western blots of the input samples for Figure 3A. (B) Western blots of the input samples for Figure 3B . (C) Glucose starvation does not affect Sfp1 phosphorylation and interaction with TORC1. Sfp1 was purified from cells expressing Sfp1-TAP and 3HA-Tor1 (HL89). For all the samples, except 0 min, cells were collected by centrifugation and cells were resuspended in YPA + 2% glucose (+Glc) or YPA (-Glc) for indicated timepoints; glucose was re-added to YPA after 45 min of starvation for 15 or 45 min (re-add Glc). (D) Diauxic shift or growth into stationary phase does not inhibit Sfp1 phosphorylation or interaction with TORC1. Sfp1 was purified from cells expressing Sfp1-TAP and 3HA-Tor1 (HL89); cells were harvested at indicated OD 600 . (E) Osmotic stress does not inhibit Sfp1 phosphorylation or interaction with TORC1. Sfp1 was purified from cells expressing Sfp1-TAP and 3HA-Tor1 (HL89); NaCl was added to a final concentration of 0.5 M for indicated times. (F) Glucose starvation and osmotic stress cause relocalization of Sfp1 from nucleus to cytoplasm. Cells carrying a genomic GFP-tagged SFP1 gene (HL115) were grown to exponential phase; cells were collected (except for no treatment sample (-) and NaCl sample) by centrifugation and resuspended to SC + Glc or SC -Glc for 45 min. To induce osmotic stress NaCl was added to final concentration of 0.5 M for 15 min. Figure 3A . Figure S4 . Sequence coverage of Sfp1 phosphopeptides by MS analysis. Covered regions of the Sfp1 sequence are shown in red, uncovered region in black. Total coverage is 81.4%. Phosphorylated residues are underlined. In the case of the two paired residues (S181/S183 and T227/S228) it is not known which one of the two residues is actually phosphorylated. Figure S5 . sfp1-1 mutation affects cell size, growth and rapamycin resistance. (A) sfp1-1 mutation has only a minor or no effect on the Sfp1-TORC1 interaction. Wildtype Sfp1-TAP and sfp1-1-TAP were purified from exponentially growing cells co-expressing Kog1-3HA. Cells were treated prior to harvesting with rapamycin (30 min) or drug vehicle. (B) sfp1-1 greatly reduces cell size in combination with SCH9 deletion. Overnight cultures were diluted and grown to logarithmic phase in YPAD medium. Cell volumes were determined using a Casy ® Model TT Cell Counter + Analyser System (Schärfe System). Cell volume shown is an average of measurements from 3 independent cultures. Standard deviations are indicated by lines above. (C) sfp1-1 greatly slows cell growth in combination with SCH9 deletion. Overnight cultures of cells were diluted into YPAD medium to OD 600 0.1 and cell growth was monitored by measuring OD 600 every hour. (D) sfp1-1 sch9Δ double mutant is hypersensitive to rapamycin. Rapamycin sensitivity of indicated strains was determined by a halo assay. Area of the inhibition zone (cm 2 ) was measured for 3 independent cultures and is shown as average values (bars) with standard deviations indicated by the lines above. A two-tailed, paired Student's t test was performed and P values were calculated comparing the indicated strains (*, P < 0.05; ***, P < 0.001). For protein level analysis of Sfp1-TAP and Act1, a strain containing an integrated GAL1 promoter-driven SFP1-TAP allele (HL201) was used. A wildtype strain (SFP1) containing integrated SFP1-TAP (HL38) was used as control. Cells were grown on SC + 2% Raffinose, and Galactose (2%) was added for indicated times. NOTE: the GAL1-SFP1 strain used in this experiment did not contain a plasmid-borne copy of SFP1, whereas the strain used in Figure 6B and S6B did. (B) Overexpression of Sfp1 leads to a large cell phenotype. Cell volumes were measured from the same cultures that were used for the Sch9 phosphorylation assay shown in Figure 6B . Cell volumes were determined using a Casy ® Model TT Cell Counter + Analyser System (Schärfe System). (C) Hyperphosphorylation of Sch9 in sfp1-1 cells. Sch9 phosphorylation in indicated strains containing a Sch9-5HA-expressing plasmid was measured using the NTCB chemical fragmentation analysis as described in Figure 6A and Experimental procedures. The relative +Pi/-Pi values are average of 3 independent experiments, with standard deviations indicated by the +/-values below. (D) Synthetic lethality of the sch9-5A mutation combined with SFP1 deletion. In the diagrams at the left of each plate photograph, the relevant genotypes and the plasmids present in each strain are indicated. All the strains on the SC-Leu-Ura plate (top panel) carry the wildtype SCH9-URA3 plasmid, which was lost following restreaking on SC-LEU + 5-FOA (5-Fluoroorotic Acid)(bottom panel). Plates where photographed after 4 days of growth at 30 0 C. (E) Combined effects of SFP1 overexpression and CHX treatment on Sch9 phosphorylation. Sfp1 was overexpressed by adding galactose (2%) for 3 hrs to cells containing an integrated GAL1 promoter-driven SFP1 allele (GAL1-SFP1) and a plasmid expressing Sch9-5HA; CHX (25 μg/ml, 10 min) was added to the indicated samples. Lysates from cells expressing Mrs6-3HA alone or together with Sfp1-TAP were analyzed as in Figure 2A ; rapamycin (200 ng/ml, 45 min) was added to the indicated sample. (B) Western blots of the input samples for Figure 7A . (C) Hyperphosphorylation of Sch9 in sfp-1-Zn2-3A mutant. Sch9 phosphorylation in wildtype and indicated SFP1 mutant cells containing a Sch9-5HA plasmid was measured using NTCB chemical fragmentation analysis. Figure S8 .
Tunicamycin inhibits Sfp1 and Sch9 signaling (A) Tunicamycin inhibits Sfp1 phosphorylation and interaction with TORC1. Sfp1 was purified from cells expressing Sfp1-TAP and 3HA-Tor1 (HL89); tunicamycin (2,0 μg/ml, for 1h or 3h) or rapamycin (200 ng/ml, 45min) were added to the cultures prior harvesting the cells. Sfp1 phosphorylation and interaction with Tor1 was detected as described in Figure 3A. (B) Tunicamycin inhibits TORC1-dependent phosphorylation of Sch9. Sch9 phosphorylation in wildtype cells containing Sch9-5HA plasmid was measured using NTCB chemical fragmentation analysis. Rapamycin (200 ng/ml, 10 min), drug vehicle (75% methanol, 2h) or tunicamycin (2,0 μg/ml, for 1h, 2h or 3h) was added prior to harvesting the cells. This study 1A, 6A, 6B, S1A, S1B, S6B, S6E
1A, 4A, S1A, S1B, S3A, S6A Shown are all the identified phosphopeptides derived from three different digestions (D): chymotrypsin (c), subtilisin (s) and a chymotrypsin/trypsin double digestion (c/t). S# and T# indicate phosphoserine and phosphothreonine, respectively, identified in an MS2 scan and in most cases corroborated by a subsequent MS3 scan. ST# indicates that the phosphorylation can not be assigned unambiguously to one of the marked residues. z indicates charge state, XCorr indicates the cross correlation score and #P indicates the number of phosphorylated residues detected in the peptide fragment. M* indicates methionine oxidation.
